Aim
Frontline Medical Sciences and Pharmaceutical Journal (FMSPJ) is an international, peer-reviewed, open-access journal dedicated to advancing scientific knowledge in medical sciences, pharmaceutical sciences, healthcare innovation, and related interdisciplinary fields. The journal aims to provide a high-quality platform for researchers, academicians, clinicians, healthcare professionals, and industry experts to publish original research findings, reviews, clinical studies, and innovative developments that contribute to the improvement of human health and medical practice.
The journal seeks to promote evidence-based research, scientific excellence, and global knowledge exchange by publishing articles that address contemporary challenges and emerging trends in medicine, pharmaceuticals, healthcare technologies, and biomedical sciences.
Scope
The journal welcomes original and unpublished manuscripts in, but not limited to, the following areas:
- Medical Sciences
- Clinical Medicine
- Pharmaceutical Sciences
- Pharmacology and Toxicology
- Drug Discovery and Drug Development
- Clinical Pharmacy
- Public Health and Epidemiology
- Community Medicine
- Healthcare Management
- Nursing and Allied Health Sciences
- Biomedical Sciences
- Biotechnology and Biopharmaceuticals
- Molecular Biology and Genetics
- Precision Medicine
- Medical Informatics
- Artificial Intelligence in Healthcare
- Telemedicine and Digital Health
- Bioinformatics
- Genomic Medicine
- Clinical Therapeutics
- Pharmaceutical Technology
- Pharmacovigilance
- Pharmaceutical Chemistry
- Nanomedicine
- Medical Imaging
- Healthcare Data Analytics
- Translational Medicine
- Regenerative Medicine
- Medical Education
- Health Policy and Healthcare Systems
- Environmental and Occupational Health
- Nutrition and Preventive Medicine
- Interdisciplinary Healthcare Research
Research Visibility and International Reach
The journal is committed to maximizing the visibility and impact of published research through Open Access publishing, DOI assignment, and indexing in recognized academic databases and discovery platforms.
Authors are encouraged to further enhance the visibility of their published work by submitting eligible articles to internationally recognized repositories and databases where applicable. Inclusion in major biomedical databases can significantly improve article discoverability, citation potential, academic credibility, and international research exposure.
For example, when authors independently submit eligible biomedical research articles to repositories and services such as PubMed-related platforms (where eligibility requirements are met), it may provide additional visibility among healthcare professionals, clinicians, researchers, universities, and medical institutions worldwide. Increased accessibility can contribute to greater recognition of the research and strengthen the scholarly authenticity and international reach of the published work.
However, acceptance into external databases and repositories is subject to the policies, eligibility criteria, and independent evaluation processes of those organizations.
Types of Articles Accepted
The journal publishes:
- Original Research Articles
- Review Articles
- Systematic Reviews
- Meta-Analyses
- Clinical Studies
- Case Reports
- Short Communications
- Technical Notes
- Perspectives
- Commentaries
- Editorials
- Healthcare Innovation Reports
Commitment to Scientific Excellence
Frontline Medical Sciences and Pharmaceutical Journal is committed to publishing high-quality, ethically conducted, and scientifically sound research that advances medical knowledge and pharmaceutical innovation. Through rigorous double-blind peer review, open-access dissemination, and international scholarly collaboration, the journal aims to support researchers in achieving greater academic impact while contributing to the advancement of global healthcare and medical science.